Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditions.
about
By reducing hexokinase 2, resveratrol induces apoptosis in HCC cells addicted to aerobic glycolysis and inhibits tumor growth in mice.Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE StudyActivating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma.Antiangiogenic treatment in hepatocellular carcinoma: the balance of efficacy and safety.Sorafenib in hepatocellular carcinoma: prospective study on adverse events, quality of life, and related feasibility under daily conditions.Sorafenib treatment is save and may affect survival of recurrent hepatocellular carcinoma after liver transplantation.
P2860
Efficacy and safety of sorafenib in advanced hepatocellular carcinoma under daily practice conditions.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Efficacy and safety of sorafen ...... der daily practice conditions.
@en
Efficacy and safety of sorafen ...... der daily practice conditions.
@nl
type
label
Efficacy and safety of sorafen ...... der daily practice conditions.
@en
Efficacy and safety of sorafen ...... der daily practice conditions.
@nl
prefLabel
Efficacy and safety of sorafen ...... der daily practice conditions.
@en
Efficacy and safety of sorafen ...... der daily practice conditions.
@nl
P2093
P2860
P1476
Efficacy and safety of sorafen ...... der daily practice conditions.
@en
P2093
Bechstein WO
Herrmann E
Lubomierski N
P2860
P304
P356
10.1179/JOC.2010.22.3.205
P577
2010-06-01T00:00:00Z